 |
 |
|
North East and North Cumbria
ICS Formulary |
| Formulary Chapter 3: Respiratory system - Full Section
|
| Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
|
|
03.01 |
Bronchodilators
(1,0)
|
|
|
Asthma (0,0)
|
|
|
Chronic obstructive pulmonary disease (0,0)
|
|
|
Croup (0,0)
|
|
03.01.01 |
Adrenoceptor agonists (0,0)
|
|
03.01.01.01 |
Selective Beta2 agonists (0,0)
|
|
|
Short-acting beta2 agonists
(5,0)
|
|
|
Long-acting beta2 agonists
(2,0)
|
|
03.01.01.02 |
Other adrenoceptor agonists
(1,0)
|
|
03.01.02 |
Antimuscarinic bronchodilators
(6,0)
|
|
|
Short Acting Anti-muscarinic Bronchodilators (0,0)
|
|
|
Long Acting Anti-muscarinic Bronchodilators (0,0)
|
|
03.01.03 |
Theophylline
(2,0)
|
|
03.01.04 |
Compound bronchodilator preparations
(5,0)
|
|
03.01.05 |
Peak flow meters, inhaler devices and nebulisers (0,0)
|
|
|
Peak flow meters (0,0)
|
|
|
Drug delivery devices
(4,0)
|
|
|
Nebulisers (0,0)
|
|
|
Nebuliser Diluent (0,0)
|
|
03.02 |
Corticosteroids
(9,0)
|
|
03.02.01 |
Long-acting beta2 agonists (ICS/LABA) (0,0)
|
|
03.02.02 |
long-acting muscarinic antagonist (ICS/LABA/LAMA)
(1,0)
|
|
|
Low dose (0,0)
|
|
|
Moderate dose (0,0)
|
|
|
High dose (0,0)
|
|
03.02.03 |
Combination products (ICS+LABA) for COPD
(8,0)
|
|
|
Triple Therapy products
(4,0)
|
|
03.03 |
Cromoglicate, related therapy and leukotriene receptor antagonists (0,0)
|
|
03.03.01 |
Cromoglicate and related therapy (0,0)
|
|
|
Related therapy (0,0)
|
|
03.03.02 |
Leukotriene receptor antagonists
(1,0)
|
|
03.03.03 |
Phosphodiesterase type-4 inhibitors
(1,0)
|
|
03.04 |
Antihistamines, hyposensitisation, and allergic emergencies (0,0)
|
|
03.04.01 |
Antihistamines (0,0)
|
|
|
Non-sedating antihistamines
(4,0)
|
|
|
Sedating antihistamines
(4,0)
|
|
03.04.02 |
Allergen Immunotherapy
(7,0)
|
|
|
Monoclonal antibodies
(6,0)
|
|
03.04.03 |
Allergic emergencies (0,0)
|
|
|
Anaphylaxis
(2,0)
|
|
|
Angioedema
(8,0)
|
|
|
Intramuscular adrenaline (epinephrine) (0,0)
|
|
|
Intravenous adrenaline (epinephrine) (0,0)
|
|
|
Self-administration of adrenaline (epinephrine) (0,0)
|
|
03.05 |
Respiratory stimulants and pulmonary surfactants (0,0)
|
|
03.05.01 |
Respiratory stimulants
(2,0)
|
|
03.05.02 |
Pulmonary surfactants
(2,0)
|
|
03.06 |
Oxygen (0,0)
|
|
|
Long-term oxygen therapy (0,0)
|
|
|
Short burst oxygen therpary (0,0)
|
|
|
Ambulatory oxygen therapy (0,0)
|
|
|
Oxygen therapy equipment (0,0)
|
|
|
Arrangements for supplying oxygen (0,0)
|
|
03.07 |
Mucolytics
(7,0)
|
|
|
Dornase alfa
(1,0)
|
|
|
Hypertonic Sodium Chloride
(1,0)
|
|
|
Mannitol
(2,0)
|
|
03.08 |
Aromatic inhalations (0,0)
|
|
03.09 |
Cough preparations (0,0)
|
|
03.09.01 |
Cough suppressants
(1,1)
|
|
|
Palliative care (0,0)
|
|
03.09.02 |
Expectorant and demulcent cough preparations
(1,0)
|
|
03.10 |
Systemic nasal decongestants
(1,0)
|
|
03.11 |
Antifibrotics
(2,0)
|
|
03.12 |
Miscellaneous
(2,0)
|
|
|
|
